RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Arthritis

A collection of news and information related to Arthritis published by this site and its partners.

Top Arthritis Articles see all

Displaying items 1-5
  • News of the Weird: Norway's Battle Against Chaos

    News of the Weird: Norway's Battle Against Chaos
    Norwegian public television (NRK), which introduced the now-legendary continuous, live log-burning show (12 hours long, with “color commentary” on the historical and cultural importance of fire), scheduled a new program for this week in its appeal to serenity (labeled “Slow TV”). On Nov. 1, NRK was to televise live, for five hours, an attempt to break the world record for producing a sweater, from shearing the sheep to spinning the wool and knitting the garment (current record: 4:51, by Australians). (In addition to the log, NRK viewers have been treated to live cams on a salmon-fishing boat and, for five days, on a cruise ship.) Said an NRK journalist, “You would think it's boring television, but we have quite good ratings for these programs.”
  • Sarah Paulson Looks Back at Her Early Career in a Hallmark TV Movie

    LOS ANGELES (Variety.com) - With the fourth incarnation of "American Horror Story" now underway -- this time out she'll be playing Siamese twins -- Sarah Paulson (who co-starred in last year's Oscar winner, "12 Years a Slave") channeled her 19-year-old...

    New breast cancer drugs boost sales at Roche

    ZURICH (Reuters) - Swiss drugs firm Roche reported better than expected third-quarter sales on Thursday, boosted by a strong performance from its new breast cancer drugs. The world's largest maker of cancer drugs said group sales rose 2 percent to 11....

    Novartis psoriasis drug benefits outweighs risk-FDA staff

    (Reuters) - The benefits of Novartis AG's anti-inflammation drug outweighed the risks in using it to treat a type of psoriasis, staff reviewers at the U.S. Food and Drug Administration said. The injectable biologic, secukinumab, is part of an eagerly...

    AbbVie board ditches planned $55 billion Shire acquisition

    LONDON (Reuters) - U.S. drugmaker AbbVie has pulled the plug on its plan to buy Dublin-based Shire , recommending shareholders vote against the proposed $55 billion takeover following new U.S. tax rules. Shire stands to be paid a break-up fee of about...